semaglutide prediabetes weight loss trial progression to diabetes Two-year effects of in adults with overweight or obesity: the STEP 5 Semaglutide in Early Type 1
Description
To reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight
And smart patent navigation
Protocol Registration INPLASY202460061.
This treatment reduces cravings and promotes fat loss for sustainable, long-term results.
Book your personalized consultation today.
